Sign up to save your podcasts
Or
Share #290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
Alex Aravanis is a leader in research and development of technologies and clinical tests utilizing the latest tools in DNA analysis and data science. In this episode, Alex delves into two interconnected topics: liquid biopsies and epigenetics. He begins by tracing the trajectory of genome sequencing and tumor sequencing, setting the stage for a detailed exploration of liquid biopsies as an early cancer detection method. The discussion encompasses key concepts such as cell-free DNA, DNA methylation, sensitivity, specificity, and the predictive values associated with liquid biopsies. Transitioning to epigenetics, Alex examines the intricate interplay of DNA methylation and aging biology and explores the possibility of using cellular reprogramming to reverse epigenetic changes that occur with aging.
We discuss:
- Alex’s background in applying engineering to problems in medicine [3:15];
- A primer on human genetics, and the history and current landscape of DNA sequencing [11:00];
- The advent and evolution of liquid biopsies for early detection of cancer [23:15];
- The role of cell-free DNA in cancer detection: how incidental findings in non-invasive prenatal testing led to the development of liquid biopsies [40:15];
- The development of a universal blood test for cancer detection and a discussion of specificity of tests [46:00];
- Advancements in cell-free DNA analysis and development of a multi-cancer screening test at GRAIL [51:00];
- DNA methylation explained [58:15];
- Optimizing cancer detection with methylation analysis of cfDNA in small blood samples [1:02:45];
- The importance of understanding sensitivity, specificity, positive predictive value, and negative predictive value in cancer screening [1:08:00];
- The performance of the GRAIL Galleri test and its ability to detect various types and stages of cancer [1:21:00];
- Do early cancer detection methods, like liquid biopsies, translate to improvement in overall survival? [1:27:45];
- The role of epigenetics in aging [1:39:30];
- How cell-free DNA methylation patterns can help identify a cancer’s tissue of origin [1:45:30];
- Cellular and epigenetic reprogramming and other exciting work in the field of aging [1:52:30]; and
- More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube
View all episodes
By Peter Attia, MD
4.7
70557,055 ratings
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
Alex Aravanis is a leader in research and development of technologies and clinical tests utilizing the latest tools in DNA analysis and data science. In this episode, Alex delves into two interconnected topics: liquid biopsies and epigenetics. He begins by tracing the trajectory of genome sequencing and tumor sequencing, setting the stage for a detailed exploration of liquid biopsies as an early cancer detection method. The discussion encompasses key concepts such as cell-free DNA, DNA methylation, sensitivity, specificity, and the predictive values associated with liquid biopsies. Transitioning to epigenetics, Alex examines the intricate interplay of DNA methylation and aging biology and explores the possibility of using cellular reprogramming to reverse epigenetic changes that occur with aging.
We discuss:
- Alex’s background in applying engineering to problems in medicine [3:15];
- A primer on human genetics, and the history and current landscape of DNA sequencing [11:00];
- The advent and evolution of liquid biopsies for early detection of cancer [23:15];
- The role of cell-free DNA in cancer detection: how incidental findings in non-invasive prenatal testing led to the development of liquid biopsies [40:15];
- The development of a universal blood test for cancer detection and a discussion of specificity of tests [46:00];
- Advancements in cell-free DNA analysis and development of a multi-cancer screening test at GRAIL [51:00];
- DNA methylation explained [58:15];
- Optimizing cancer detection with methylation analysis of cfDNA in small blood samples [1:02:45];
- The importance of understanding sensitivity, specificity, positive predictive value, and negative predictive value in cancer screening [1:08:00];
- The performance of the GRAIL Galleri test and its ability to detect various types and stages of cancer [1:21:00];
- Do early cancer detection methods, like liquid biopsies, translate to improvement in overall survival? [1:27:45];
- The role of epigenetics in aging [1:39:30];
- How cell-free DNA methylation patterns can help identify a cancer’s tissue of origin [1:45:30];
- Cellular and epigenetic reprogramming and other exciting work in the field of aging [1:52:30]; and
- More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube
More shows like The Peter Attia Drive
View all
Boundless Life
5,019 Listeners
The Human Upgrade with Dave Asprey
7,170 Listeners
The Rich Roll Podcast
11,749 Listeners
FoundMyFitness
5,293 Listeners
High Intensity Health with Mike Mutzel, MS
1,221 Listeners
The Ready State Podcast
490 Listeners
Modern Wisdom
3,701 Listeners
The Proof with Simon Hill
2,602 Listeners
The Genius Life
4,873 Listeners
Dhru Purohit Show
3,496 Listeners
The Dr. Hyman Show
9,358 Listeners
Huberman Lab
28,300 Listeners
Longevity by Design
177 Listeners
The Matt Walker Podcast
896 Listeners
The Dr. Gabrielle Lyon Show
1,138 Listeners